Zhejiang Wecome Pharmaceutical Co., Ltd. Class ASZSE: 300878

Zhejiang Wecome Pharmaceutical Co., Ltd. Class A EGM RESOLUTION 2026-07-16

· Issued by Zhejiang Wecome Pharmaceutical Co., Ltd. Class A via Shenzhen Stock Exchange
The Company held its 1st Extraordinary General Meeting of 2026 on 15 July 2026, during which the following proposal(s) was/were approved:
1. By-election of non-independent directors
2. Formulation of the remuneration management system for directors and senior management
3. Change of the purpose of repurchased shares for cancellation, decrease of the Company's registered capital and amendments to the Company's articles of association

Company analysis

Earlier from Zhejiang Wecome Pharmaceutical Co., Ltd. Class A

All Zhejiang Wecome Pharmaceutical Co., Ltd. Class A news releases